Prognostic impact of heart failure, chronic kidney disease and atherosclerotic disease alone or combined in an elderly population: a retrospective cohort study based on electronic health record data
Our results support the concept of an atherosclerotic cardiorenal phenotype, with a very high risk of mortality, cardiovascular and renal adverse events. Implementation strategies are required to target these conditions simultaneously.
Authors
- Daniel Seabra (ORCID: https://orcid.org/0000-0002-5299-9341)
- Cristina Gavina (ORCID: https://orcid.org/0000-0003-2553-8264)
- Filipa Bernardo (ORCID: https://orcid.org/0000-0001-8245-0520)
- Tiago Taveira‐Gomes (ORCID: https://orcid.org/0000-0002-0998-6000)
- Rita Lopes (ORCID: https://orcid.org/0000-0002-2103-4336)
- João Pedro Ferreira (ORCID: https://orcid.org/0000-0002-2304-6138)
Institutions
- Universidade do Porto (PT)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- Centre d’Investigation Clinique Innovation Technologique de Nancy (FR)
- Administração Regional de Saúde de Lisboa e Vale do Tejo (PT)
- Centre d'Investigation Clinique Pierre Drouin (FR)
- AstraZeneca (Portugal) (PT)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1136/bmjopen-2024-094853
- Citations
- 1
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- AstraZeneca